Mumps-Only Vaccine Availability
No, you cannot receive a mumps-only vaccine in the United States—mumps vaccine is only available as part of the combination MMR (measles-mumps-rubella) vaccine. 1
Why Mumps-Only Vaccine Is Not Available
- The FDA-approved mumps vaccine (M-M-R II) contains weakened forms of measles virus, mumps virus, and rubella virus combined in a single formulation. 1
- There is no standalone mumps vaccine licensed or distributed in the United States. 1
- The combination MMR vaccine has been the standard approach since the 1970s, driven by both immunologic efficacy and cost-effectiveness (benefit-cost ratio of approximately 14:1 for the combined vaccine). 2
Clinical Implications
- If you need mumps protection, you must receive the full MMR vaccine, even if you only require immunity to one component. 1
- The MMR vaccine is safe and effective in adolescents and adults, with serious adverse events occurring at rates ≤6 per 100,000 doses. 3
- Common non-serious reactions include injection site reactions (157 per 100,000 doses), arthropathy (263 per 100,000 doses), and rash (113 per 100,000 doses). 3
Dosing Recommendations
- Adults with no evidence of immunity require a 2-dose series administered at least 4 weeks apart. 4
- Evidence of immunity includes: born before 1957 (except healthcare personnel), documented receipt of MMR, or laboratory confirmation of immunity. 4
- Students in postsecondary institutions, international travelers, household contacts of immunocompromised persons, and healthcare workers are particularly advised to ensure they have received 2 doses if they lack evidence of immunity. 4
Important Contraindications
- Do not administer MMR if the patient:
- Has severe immunocompromising conditions (MMR is contraindicated). 4
- Is pregnant or planning pregnancy within 1 month (counsel to avoid pregnancy for 1 month post-vaccination). 1
- Has a weakened immune system, including those taking high-dose steroids. 1
- Has active untreated tuberculosis or current fever. 1
- Has a history of severe allergic reaction to vaccine components (including gelatin). 1
Common Pitfall to Avoid
- Do not delay vaccination seeking a monovalent mumps vaccine—it does not exist in the U.S. market, and postponing protection against mumps (especially during outbreaks in close-contact settings) increases risk of infection. 5
- Mumps outbreaks have resurged even in highly vaccinated populations, particularly in high-density settings, making timely vaccination with available MMR critical. 5